Updated Jul 16, 2026
Carter Charles Ross has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Carter Charles Ross is named in SEC filings in connection with Ovid Therapeutics Inc. as of 2026-07-08. The available SEC context does not provide his exact title or responsibilities, and public biographical information beyond the filings is not readily available. The information suggests an association with Ovid Therapeutics but lacks corroborating details in widely available sources.
| Role | Insider |
|---|---|
| Notability | 40/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-08 | OVID | Ovid Therapeutics Inc. | A — Grant or award | 50.0K | $0.00 |
Carter Charles Ross is named in SEC filings in connection with Ovid Therapeutics Inc. as of 2026-07-08. The available SEC context does not provide his exact title or responsibilities, and public biographical information beyond the filings is not readily available. The information suggests an association with Ovid Therapeutics but lacks corroborating details in widely available …
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Carter Charles Ross profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.